Mark Eisner - 04 Oct 2021 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role: Chief Medical Officer
Signature: /s/ Dorothy Pacini, Attorney-in-fact
Issuer symbol: FGEN
Transactions as of: 04 Oct 2021
Net transactions value: $0
Form type: 4
Filing time: 06 Oct 2021, 19:25:59 UTC
Next filing: 03 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FGEN	Common Stock	Award	$0	+74,520	+213%	$0.000000	109,520	04 Oct 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FGEN	Stock Option (Right to Buy)	Award	$0	+44,520		$0.000000	44,520	04 Oct 2021	Common Stock	44,520	$9.93	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on each December 31, 2021, March 31, 2022, September 30, 2022 and March 31, 2023.
F2	Fifty percent of the shares subject to the option vests on each September 30, 2022 and March 31, 2023.